ACTG Announces Behavioral Health and Implementation Study to Optimize Long-Acting HIV Treatment among People who have Struggled to Maintain HIV Suppression

CHAPEL HILL, N.C., July 17, 2026 (GLOBE NEWSWIRE) — ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of A5432, a study assessing factors that may affect how long-acting antiretroviral therapy (ART) is used and researched among people living with HIV who previously have been unable to […]